Elevated TfR1 expression has been correlated with increased tumor aggressiveness, rapid proliferation, and poor prognosis, particularly in estrogen receptor-negative and triple-negative breast cancer (TNBC) subtypes[8]. Here, TFRC is linked to neoplasm.